A phase I/IIa trial of VBI-1901 in patients with glioblastoma multiforme

Trial Profile

A phase I/IIa trial of VBI-1901 in patients with glioblastoma multiforme

Planning
Phase of Trial: Phase I/II

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs VBI 1901 (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions; First in man
  • Sponsors VBI Vaccines
  • Most Recent Events

    • 10 Nov 2016 According to a VBI Vaccines Inc. media release, company anticipates filing an Investigational New Drug ("IND") application with the U.S. FDA in the first half of 2017 to initiate this study and also Fast Track designation will be considered during IND submission.
    • 24 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top